Gene expression signatures that classify the mode of invasion of primary oral squamous cell carcinomas

Molecular Carcinogenesis

Volumn 47, Issue 10, 2008, Pages 744-756

  Kondoh, Nobuo ^a   Ishikawa, Toshio ^c   Ohkura, Shuri ^b   Arai, Masaaki ^b   Hada, Akiyuki ^b   Yamazaki, Yutaka ^d   Kitagawa, Yoshimasa ^d   Shindoh, Masanobu ^d   Takahashi, Masayuki ^b   Ando, Toshifumi ^b   Sato, Yasunori ^b   Izumo, Toshiyuki ^e   Hitomi, Kiyotaka ^f   Yamamoto, Mikio ^b  

^a ASAHI UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c ISHIHARA SANGYO KAISHA LTD   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e SAITAMA CANCER CENTER   (Japan)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

Gene expression; Microarray; Oral squamous cell carcinoma; Quantitative polymerase chain reaction; Supervised learning method

Indexed keywords

COMPLEMENTARY DNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ISOLATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE; VALIDATION STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETICS; MOUTH TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, SQUAMOUS CELL; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 52649092945     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20431     Document Type: Article

References (40)

1. Ohkura S, Kondoh N, Hada A, et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 2005;41:607-613.
2. Kondoh N, Ohkura S, Arai M, et al. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma. Oral Oncol 2007;43:455-462.
3. Iizuka N, Oka M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002;62:3939-3944.
4. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15149-15154.
5. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-186.
6. Marchet A, Mocellin S, Belluco C, et al. Gene expression profile of primary gastric cancer: Towards the prediction of lymph node status. Ann Surg Oncol 2007;14:1058-1064.
7. Kato Y, Uzawa K, Saito K, et al. Gene expression pattern in oral cancer cervical lymph node metastasis. Oncol Rep 2006;16:1009-1014.
8. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24:1244-1251.
9. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinoma using patterns of gene expression. Mol Cell 2004;5:489-500.
10. Chung CH, Parker JS, Ely K, et al. Gene expression profiles identify epitherial-to-mesenchymal transition and activation of nuclear factor-kB signaling as chsaracteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 2006;66:8210-8218.
11. Gupta GP, Massague J. Cancer metastasis: Building a framework. Cell 2006;127:679-695.
12. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983;51:2175-2180.
13. Kaihara T, Kusaka T, Kawamata H, et al. Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma. Pathobiology 2001;69:172-178.
14. Nakayama A, Ogawa A, Fukuta Y, Kudo K. Relation between lymphatic vessel diameter and clinicopathologic parameters in squamous cell carcinomas of the oral region. Cancer 1999;86:200-206.
15. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
16. Fisher NA. The use of multiple measurements in taxonomic problems. Ann Eugen 1936;7:179-188.
17. Goldgerg DE. Genetic algorithm in search, optimization and machine learning. Reading (MA): Addison-Wesley; 1989. pp. 1-26.
18. Hitomi K, Presland RB, Nakayama T, et al. Analysis of epitherial-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies. J Dermatol Sci 2003;32:95-103.
19. Chen BS, Wang MR, Xu X, et al. Transglutaminase-3, an esophageal cancer-related gene. Int J Cancer 2000;88:862-865.
20. Zhang JS, Gong A, Young CY. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer. Oncogene 2007;26:111-122.
21. Tesfaigzi Y, Wright PS, Belinsky SA. SPRR1B overexpression enhances entry of cells into the GO phase of the cell cycle. Am J Physiol Lung Cell Mol Physiol 2003;285:L889-L898.
22. Asanoma K, Matsuda T, Kondo H, et al. NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics 2003;81:15-25.
23. Chen Y, Petersen S, Pacyna-Gengelbach M, Pietas A, Petersen I. Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 2003;64:450-458.
24. Lemaire F, Millon R, Muller D, et al. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. Br J Cancer 2004;91:258-261.
25. Schieber A, Frank RW, Ghisla S. Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase. Eur J Biochem 1992;206:491-502.
26. Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem Pharmacol 1995;49:421-440.
27. Kelner MJ, Estes L, Rutherford M, Uglik SF, Peitzke JA. Heterologous expression of carbonyl reductase: Demonstration of prostaglandin 9-ketoreductase activity and paraquat resistance. Life Sci 1997;61:2317-2322.
28. Ismail E, Al-Mulla F, Tsuchida S, et al. Carbonyl reductase: A novel metastasis-modulating function. Cancer Res 2000;60:1173-1176.
29. Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 2001;85:1032-1036.
30. Takenaka K, Ogawa E, Oyanagi H, Wada H, Tanaka F. Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1972-1975.
31. Milde-Langosch K, Kappes H, Riethdorf S, Loning T, Bamberger AM. FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat 2003;77:265-275.
32. Delebecq TJ, Porte H, Zerimech F, et al. Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer. Clin Cancer Res 2000;6:1086-1092.
33. Sakai N, Kusunoki M, Nishida M, Toyoguchi T, Fukutomi H, Sakiyama H. Tumorigenicity of BALB3T3 A31 cells transfected with hamster-complement-C1s cDNA. Int J Cancer 1994;58:309-313.
34. Sakiyama H, Inaba N, Toyoguchi T, et al. Immunolocalization of complement C1s and matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur. Cell Tissue Res 1994;277:239-245.
35. Fang X, Burg MA, Barritt D, Dahlin-Huppe K, Nishiyama A, Stallcup WB. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol Biol Cell 1999;10:3373-3387.
36. Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005;115:1163-1176.
37. Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004;64:2397-2405.
38. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: A small protein with major functions. Glycobiology 2006;16:137R-157R.
39. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001;20:7437-7446.
40. Corcione A, Arduino N, Ferretti E, et al. CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells. Clin Cancer Res 2004;10:964-971.